Taiwan Biomaterial Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 10, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	1,703	1,436	1,315	1,457	818	980
Market Cap Growth	14.23%	9.26%	-9.80%	78.08%	-16.50%	-22.15%
Enterprise Value	1,393	1,195	1,060	1,212	726	797
Last Close Price	40.55	34.20	31.30	34.50	24.65	28.55
PE Ratio	30.03	-	-	43.18	-	-
PS Ratio	8.38	14.87	18.05	11.45	19.64	54.22
PB Ratio	2.50	2.29	2.09	2.26	1.94	2.09
P/TBV Ratio	2.51	2.30	2.10	2.26	1.94	2.10
P/FCF Ratio	24.46	97.44	-	-	-	-
P/OCF Ratio	23.81	77.95	-	49.73	-	-
EV/Sales Ratio	6.85	12.37	14.55	9.52	17.42	44.07
EV/EBITDA Ratio	18.48	1206.78	-	33.65	-	-
EV/EBIT Ratio	23.53	-	-	47.59	-	-
EV/FCF Ratio	20.01	81.05	-	-	-	-
Debt / Equity Ratio	0.08	0.09	0.10	0.11	0.18	0.16
Debt / EBITDA Ratio	0.71	10.26	22.21	1.65	-	-
Debt / FCF Ratio	0.77	3.87	-	-	-	-
Net Debt / Equity Ratio	-0.45	-0.41	-0.39	-0.41	-0.19	-0.28
Net Debt / EBITDA Ratio	-4.37	-258.43	106.60	-7.33	1.52	2.24
Net Debt / FCF Ratio	-4.45	-17.36	19.12	41.52	1.45	0.68
Asset Turnover	0.28	0.14	0.10	0.20	0.07	0.03
Inventory Turnover	1.92	0.88	0.78	2.66	1.20	0.59
Quick Ratio	10.85	12.61	9.71	12.81	2.44	7.59
Current Ratio	12.15	14.39	11.30	13.74	2.77	8.21
Return on Equity (ROE)	8.71%	-0.28%	-1.59%	6.31%	-10.64%	-11.15%
Return on Assets (ROA)	5.05%	-0.99%	-1.23%	2.47%	-6.30%	-6.60%
Return on Capital Employed (ROCE)	8.10%	-1.70%	-2.10%	3.60%	-11.60%	-12.00%
Earnings Yield	3.34%	-0.12%	-0.77%	2.32%	-5.80%	-5.65%
FCF Yield	4.09%	1.03%	-0.97%	-0.44%	-6.64%	-19.82%
Dividend Yield	-	-	-	0.58%	-	-
Buyback Yield / Dilution	-0.08%	-	-2.73%	-23.90%	-	-3.96%
Total Shareholder Return	-0.08%	-	-2.73%	-23.32%	-	-3.96%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.